8-KThe WireRoutine
Reg FD Disclosure
Filed Feb 2, 2026 · 4mo ago · Accession 0001398733-26-000005
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aquestive Therapeutics, Inc.
- Ticker
- AQST
- CIK
- 1398733
- Form type
- 8-K
- Filing date
- Feb 2, 2026
- Report date
- Jan 30, 2026
- Document
- aqst-20260130.htm
- Size
- 3.7 MB